Physician

Madhuri Yalamanchili, MD

According to 2025 Medicare claims, Madhuri Yalamanchili, MD (NPI: 1528057189) practices hematology/oncology in the Binghamton, NY market, with the plurality of this provider's patient population coming from Broome, NY. This provider's primary affiliated billing organization is BROOME ONCOLOGY LLC (NPI: 1518956176; TIN: 16-1611703) and primary practice location at 13905-4246.

Yalamanchili's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 724 traditional Medicare patients, billed 128,599 HCPCS/CPT codes, and received $1,851,615 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,141 prescription claims across 362 beneficiaries totaling $2,562,918 in drug costs, led by Lynparza (Olaparib). DME data shows 13 claims. Open Payments data shows 160 records totaling $4,102. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,559,924 to $1,851,615. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,225,159 and ending at $2,562,918. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,016	141,771	$1,559,924
2016	820	95,031	$1,092,507
2017	781	102,412	$1,156,662
2018	750	103,039	$1,298,688
2019	769	90,546	$1,354,246
2020	674	74,802	$1,222,649
2021	662	85,238	$1,642,449
2022	659	115,776	$1,810,493
2023	675	119,942	$1,729,956
2024	724	128,599	$1,851,615

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	282	1,127	$1,225,159
2016	236	938	$1,082,656
2017	231	837	$822,363
2018	215	720	$1,228,773
2019	243	820	$1,388,617
2020	250	894	$1,342,086
2021	254	793	$1,201,701
2022	278	781	$884,074
2023	326	939	$1,538,312
2024	362	1,141	$2,562,918

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	12	161	$40,551
2016	N/R	22	$763
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	30	$3,356
2021	N/R	13	$1,490
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	13	$578

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	405	810	$87
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	266	361	$64
80053	Blood test, comprehensive group of blood chemicals	359	816	$10
36415	Insertion of needle into vein for collection of blood sample	419	1,040	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	408	981	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lynparza	Olaparib	22	675	$346,685
Lumakras	Sotorasib	18	540	$259,795
Nubeqa	Darolutamide	16	480	$213,823
Xtandi	Enzalutamide	13	390	$164,839
Calquence	Acalabrutinib Maleate	18	540	$158,562

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	13	$578

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	160	$4,102	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Madhuri Yalamanchili, MD?

Tedicare shows public-source Medicare data for Madhuri Yalamanchili, MD (NPI 1528057189), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Madhuri Yalamanchili, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Madhuri Yalamanchili, MD?

Madhuri Yalamanchili, MD is linked to BROOME ONCOLOGY LLC (billing NPI 1518956176) in the available physician profile data.

Does Madhuri Yalamanchili, MD have Open Payments data?

Madhuri Yalamanchili, MD has 160 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.